Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,938 | 662 | 99.0% |
| Education | $113.07 | 5 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,796 | 136 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $1,387 | 83 | $0 (2024) |
| ITI, Inc. | $982.14 | 46 | $0 (2023) |
| Allergan, Inc. | $810.43 | 62 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $796.82 | 53 | $0 (2022) |
| Neurocrine Biosciences, Inc. | $606.72 | 19 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $583.22 | 40 | $0 (2024) |
| Lundbeck LLC | $432.55 | 26 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $399.85 | 22 | $0 (2024) |
| Ironshore Pharmaceuticals Inc. | $310.53 | 8 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,158 | 65 | ABBVIE INC. ($248.10) |
| 2023 | $2,546 | 159 | ABBVIE INC. ($813.33) |
| 2022 | $1,640 | 108 | ABBVIE INC. ($500.87) |
| 2021 | $1,727 | 92 | ITI, Inc. ($375.44) |
| 2020 | $514.68 | 35 | Allergan, Inc. ($131.28) |
| 2019 | $1,573 | 91 | Allergan Inc. ($289.93) |
| 2018 | $1,135 | 73 | Allergan Inc. ($252.70) |
| 2017 | $756.96 | 44 | Otsuka America Pharmaceutical, Inc. ($199.13) |
All Payment Transactions
667 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.58 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.11 | General |
| Category: PSYCHIATRY | ||||||
| 12/16/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: PSYCHIATRY | ||||||
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $27.84 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $19.81 | General |
| Category: PSYCHIATRY | ||||||
| 12/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: PSYCHIATRY | ||||||
| 12/05/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $28.39 | General |
| Category: Neuropsychiatry | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $23.60 | General |
| Category: Central Nervous System | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $24.79 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Neuropsychiatry | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: PSYCHIATRY | ||||||
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $22.78 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $25.95 | General |
| Category: PSYCHIATRY | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 131 | 360 | $87,760 | $28,292 |
| 2022 | 5 | 209 | 522 | $118,507 | $39,194 |
| 2021 | 4 | 235 | 525 | $114,441 | $47,337 |
| 2020 | 4 | 206 | 471 | $82,136 | $28,141 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 131 | 360 | $87,760 | $28,292 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 421 | $102,045 | $34,122 | 33.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $7,980 | $2,827 | 35.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 20 | $6,580 | $1,947 | 29.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 14 | 51 | $1,033 | $151.44 | 14.7% |
| 82746 | Folic acid level, serum | Office | 2022 | 11 | 11 | $869.00 | $147.85 | 17.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 159 | 425 | $89,830 | $37,631 | 41.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 39 | 51 | $13,825 | $5,568 | 40.3% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 26 | 26 | $10,320 | $4,070 | 39.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 23 | $465.75 | $69.00 | 14.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 147 | 346 | $67,800 | $22,550 | 33.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 24 | 88 | $6,930 | $2,724 | 39.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 21 | 22 | $5,280 | $2,006 | 38.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 14 | 15 | $2,126 | $861.30 | 40.5% |
About Dr. Nancy Graves, M.D
Dr. Nancy Graves, M.D is a Psychiatry healthcare provider based in Texarkana, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013138361.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nancy Graves, M.D has received a total of $11,051 in payments from pharmaceutical and medical device companies, with $1,158 received in 2024. These payments were reported across 667 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($10,938).
As a Medicare-enrolled provider, Graves has provided services to 781 Medicare beneficiaries, totaling 1,878 services with total Medicare billing of $142,965. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Texarkana, TX
- Active Since 05/02/2007
- Last Updated 10/25/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1013138361
Products in Payments
- VRAYLAR (Drug) $2,602
- REXULTI (Drug) $1,419
- CAPLYTA (Drug) $1,077
- LATUDA (Drug) $796.82
- INGREZZA (Drug) $606.72
- TRINTELLIX (Drug) $511.36
- ABILIFY MAINTENA (Drug) $315.92
- AUSTEDO (Drug) $254.68
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $234.98
- Dyanavel XR (Drug) $225.12
- SUNOSI (Drug) $218.81
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $179.60
- Auvelity (Drug) $167.47
- NUEDEXTA (Drug) $142.70
- INVEGA SUSTENNA (Drug) $134.82
- WAKIX (Drug) $131.62
- Evekeo (Drug) $131.15
- BELSOMRA (Drug) $131.07
- Sunosi (Drug) $129.19
- Austedo XR (Drug) $126.88
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Texarkana
Edward Tobey, Md, MD
Psychiatry — Payments: $6,813
Gregory Montoya, Md, MD
Psychiatry — Payments: $6,675
Dr. Donna Brister, D.o, D.O
Psychiatry — Payments: $4,726
Mr. Ramneesh Baweja, Md, MD
Psychiatry — Payments: $451.06
Catherine Pearson, Aprn, APRN
Psychiatry — Payments: $16.86
Dr. Marianne Seidel, M.d, M.D
Psychiatry